Last update 01 Nov 2024

Beijing Ruicy Gene Therapy Institute for Rare Diseases

Nonprofit|
2014|
China

Overview

Basic Info

Introduction
Beijing Ruicy Gene Therapy Institute for Rare Diseases, commonly referred to as RDGT Institute, was formally established in September 2014 as a non-profit scientific research organization registered in Beijing under the Bureau of Civil Affairs. The Institute operates as a private non-enterprise entity dedicated to the public good in both science and industry, focusing primarily on advancing the development of gene therapies for rare diseases and harnessing scientific advancements to serve the rare disease community. As the pioneering non-profit research entity in China to concentrate exclusively on gene therapy for rare ailments, the RDGT Institute is committed to conducting basic research in gene therapy for rare diseases, developing related pharmaceuticals, and facilitating the progression of these treatments into clinical trials.

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

No data posted
Login to keep update

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free